Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
NCT02033018
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Choroidal Retinal Neovascularization
Interventions
DRUG:
Aflibercept Injection
Sponsor
Instituto de Olhos de Goiania